Novartis Investigative Site — Hirakata, Osaka

Public research footprint of Novartis Investigative Site, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetic Macular Edema · Non-Small Cell Lung Cancer · Metastatic Castration-resistant Prostate Cancer (mCRPC) · Advanced HR+/HER2- Breast Cancer

Recently updated registry entries

NCT07570979 — A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in… (Recruiting)
NCT07604571 — Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2… (Recruiting)
NCT05976230 — Special Drug Use Surveillance of Entresto Tablets (Hypertension) (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Novartis Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.